Der Merkurstab | November/Dezember 2021 | 16,00 Euro (inkl. Mwst., zzgl. Versandkosten)
Artikel | Use of supportive anthroposophic medicine in a German paediatric oncology centre Use of supportive anthroposophic medicine in a German integrative paediatric oncology centre |
Autoren | Tycho Jan Zuzak, Rico Seiler, Thomas Ostermann, et al. |
Seiten | 471-477 |
Volume | 74 |
Zusammenfassung
Introduction: The only German centre for integrative
paediatric oncology (PO) at the Gemeinschaftskrankenhaus
Herdecke offers integrative-anthroposophic
supportive treatment in addition to conventional
therapy.
Methods: All paediatric oncological inpatients between
1999 and 2008 were retrospectively documented.
Patient and parent experiences were analysed
by a modified ZUF-8 questionnaire.
Results: Among the 116 patients, 97.0% received some
form of supportive integrative-anthroposophic therapies.
Non-drug treatments are applied in 79.3% of patients
and 94.0% of patients received anthroposophic
drug treatment, whereby mistletoe therapy (75.0%)
was most frequently used. Our survey revealed that
parents were highly satisfied with the integrative PO
treatment.
Conclusion: Integrative therapies are well integrated
in the clinical routine of the integrative PO centre.
Presented data make anthroposophic medicine more
transparent and comprehensible to physicians, patients
and parents, as well as to health professionals
and service providers. Further prospective controlled
trials are necessary to estimate effectiveness of such
integrative approaches.
Abstract
Introduction: The only German centre for integrative
paediatric oncology (PO) at the Gemeinschaftskrankenhaus
Herdecke offers integrative-anthroposophic
supportive treatment in addition to conventional
therapy.
Methods: All paediatric oncological inpatients between
1999 and 2008 were retrospectively documented.
Patient and parent experiences were analysed
by a modified ZUF-8 questionnaire.
Results: Among the 116 patients, 97.0% received some
form of supportive integrative-anthroposophic therapies.
Non-drug treatments are applied in 79.3% of patients
and 94.0% of patients received anthroposophic
drug treatment, whereby mistletoe therapy (75.0%)
was most frequently used. Our survey revealed that
parents were highly satisfied with the integrative PO
treatment.
Conclusion: Integrative therapies are well integrated
in the clinical routine of the integrative PO centre.
Presented data make anthroposophic medicine more
transparent and comprehensible to physicians, patients
and parents, as well as to health professionals
and service providers. Further prospective controlled
trials are necessary to estimate effectiveness of such
integrative approaches.